Imjudo 25 mg/1,25 ml, Konzentrat zur Herstellung einer Infusionslösung

7680687060011 CH-68706 Konzentrat
Imjudo 25 mg/1,25 ml, Konzentrat zur Herstellung einer Infusionslösung
Imjudo 25 mg/1,25 ml, Konzentrat zur Herstellung einer Infusionslösung
Imjudo 25 mg/1,25 ml, Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
11/07/2025
Summary of Product Characteristics
Français
11/07/2025
Summary of Product Characteristics
Italien
11/07/2025

Detailed composition

Substance Quantity Type Category
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.012 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 1570.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2025

Authorization holder

AstraZeneca AG

6340 Baar

Authorization information

Swissmedic authorization number
68706
Drug name
Imjudo, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
L01FX20
Authorization status
Z
Dispensing category
A
First authorization
13/09/2023
Authorization expiration date
12/09/2028
IT Number
07.16.1.
Domain
Human medicine
Field of application
Hepatozelluläres Karzinom

Package details

Description (FR)
IMJUDO conc perf 25 mg/1.25ml vial 1.25 ml
Description (DE)
IMJUDO Inf Konz 25 mg/1.25ml Vial 1.25 ml
Market launch
13/09/2023
Narcotic (BTM)
No

Other package sizes (1)

IMJUDO conc perf 300 mg/15ml vial 15 ml
1 DUR
GTIN: 7680687060028
View